- Home
- ANTA vs VOR Comparison
ANTA vs VOR Comparison
Compare ANTA & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTA
- VOR
- Stock Information
- Founded
- ANTA 2022
- VOR 2015
- Country
- ANTA Singapore
- VOR United States
- Employees
- ANTA N/A
- VOR 168
- Industry
- ANTA Investment Bankers/Brokers/Service
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- ANTA Finance
- VOR Health Care
- Exchange
- ANTA Nasdaq
- VOR Nasdaq
- Market Cap
- ANTA 256.6M
- VOR 261.2M
- IPO Year
- ANTA 2025
- VOR 2021
- Fundamental
- Price
- ANTA $12.50
- VOR $1.93
- Analyst Decision
- ANTA Strong Buy
- VOR Buy
- Analyst Count
- ANTA 2
- VOR 7
- Target Price
- ANTA $19.25
- VOR $3.77
- AVG Volume (30 Days)
- ANTA 34.5K
- VOR 5.3M
- Earning Date
- ANTA 08-12-2025
- VOR 08-15-2025
- Dividend Yield
- ANTA N/A
- VOR N/A
- EPS Growth
- ANTA N/A
- VOR N/A
- EPS
- ANTA 0.29
- VOR N/A
- Revenue
- ANTA $51,404,954.00
- VOR N/A
- Revenue This Year
- ANTA $53.90
- VOR N/A
- Revenue Next Year
- ANTA $40.91
- VOR N/A
- P/E Ratio
- ANTA $42.26
- VOR N/A
- Revenue Growth
- ANTA 320.96
- VOR N/A
- 52 Week Low
- ANTA $10.19
- VOR $0.13
- 52 Week High
- ANTA $27.72
- VOR $3.29
- Technical
- Relative Strength Index (RSI)
- ANTA N/A
- VOR 51.01
- Support Level
- ANTA N/A
- VOR $2.02
- Resistance Level
- ANTA N/A
- VOR $2.14
- Average True Range (ATR)
- ANTA 0.00
- VOR 0.18
- MACD
- ANTA 0.00
- VOR -0.08
- Stochastic Oscillator
- ANTA 0.00
- VOR 4.29
About ANTA Antalpha Platform Holding Company Ordinary Shares
Antalpha Platform Holding Co provides financing, technology and risk management solutions to the digital asset industry. It is a provider of supply chain financing solutions to institutional and corporate participants in the Bitcoin mining industry, offering loans secured by Bitcoin and Bitcoin mining machines. It has developed a technology platform, Antalpha Prime, which enables customers to apply for and manage their digital asset loans while allowing to closely monitor collateral positions.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.